These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15279387)

  • 1. [Analyses of genetic risk factors associated to chronic nephropathy of renal transplant: genetic polymorphisms of cytokynes, adhesion molecules, platelet-coagulation system and cardiovascular risk markers].
    Cobo M; Barrios Y; Iñigo P; Bigo C; Alvarez A; Martín B; Campistol JM; Hernández D; Salido E; Torres A
    Nefrologia; 2004; 24 Suppl 4():49-56. PubMed ID: 15279387
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic polymorphisms and the fate of the transplanted organ.
    Krüger B; Schröppel B; Murphy BT
    Transplant Rev (Orlando); 2008 Apr; 22(2):131-40. PubMed ID: 18631866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene polymorphism association studies in dialysis: cardiovascular disease.
    Rao M; Jaber BL; Balakrishnan VS;
    Semin Dial; 2005; 18(3):217-25. PubMed ID: 15934969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphism of coagulation factors as a cardiovascular risk factor].
    Iacoviello L; Donati MB
    Minerva Cardioangiol; 1999 Nov; 47(11):401-2. PubMed ID: 10641411
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelial nitric oxide synthase polymorphisms are associated with hypertension and cardiovascular disease in renal transplantation.
    Bhandary UV; Tse W; Yang B; Knowles MR; Demaine AG
    Nephrology (Carlton); 2008 Jun; 13(4):348-55. PubMed ID: 18331440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of gene polymorphisms in adhesion molecules and inflammation mediators as risk factors for coronary heart disease and myocardial infarction--an overview].
    Grsković B; Pasalić D; Ferencak G; Stavljenić-Rukavina A
    Acta Med Croatica; 2008 Feb; 62(1):41-52. PubMed ID: 18365499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The genetic component of coronary risk. II].
    Carluccio M; Vanuzzo D; Pilotto L; Fioretti P; Quadrifoglio F; Diviacco S; Mariani M; De Caterina R
    Cardiologia; 1999 Feb; 44(2):155-67. PubMed ID: 10208052
    [No Abstract]   [Full Text] [Related]  

  • 8. [Genetic predisposition to cardiovascular diseases].
    Stajszczyk M; Gmiński J
    Przegl Lek; 2000; 57(1):48-51. PubMed ID: 10907371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular disease after renal transplantation].
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of hypoxia-inducible factor-1 alpha and cardiovascular disease in hemodialysis patients.
    Zheng ZL; Hwang YH; Kim SK; Kim S; Son MJ; Ro H; Sung SA; Lee HH; Chung WK; Joo KW; Yang J
    Nephron Clin Pract; 2009; 113(2):c104-11. PubMed ID: 19602906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are inflammatory cytokines the "evil humors" that increase morbidity and cardiovascular mortality in chronic kidney disease?
    Maltzman JS; Berns JS
    Semin Dial; 2005; 18(5):441-3. PubMed ID: 16191187
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical risk markers: a novel area for better prediction of renal risk?
    Stuveling EM; Bakker SJ; Hillege HL; de Jong PE; Gans RO; de Zeeuw D
    Nephrol Dial Transplant; 2005 Mar; 20(3):497-508. PubMed ID: 15735241
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M; Ksiazek P; Zukowski P; Benedyk-Lorens E; Orlowska-Kowalik G
    Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of clotting factors and coronary heart disease.
    Donati MB; Iacoviello L
    Haematologica; 2001 Nov; 86(11 Suppl 2):28-30. PubMed ID: 11926770
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomic medicine, gene polymorphisms, and human biological diversity.
    Balakrishnan VS; Rao M; Jaber BL;
    Semin Dial; 2005; 18(1):37-40. PubMed ID: 15663763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
    Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms that predict outcome and need for treatment in cardiovascular disease.
    Yende S; Wunderink RG
    Curr Opin Crit Care; 2006 Oct; 12(5):420-5. PubMed ID: 16943719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cytokine gene polymorphisms on IgA nephropathy.
    Bantis C; Heering P; Aker S; Kuhr N; Grabensee B; Ivens K
    Ren Fail; 2008; 30(2):135-40. PubMed ID: 18300111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic factors associated with skin cancer in renal transplant patients.
    Laing ME; Kay E; Conlon P; Murphy GM
    Photodermatol Photoimmunol Photomed; 2007; 23(2-3):62-7. PubMed ID: 17523926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion molecule polymorphisms in acute renal allograft rejection.
    Khazen D; Jendoubi-Ayed S; Gorgi Y; Sfar I; Abderrahim E; Ben Abdallah T; Ayed K
    Transplant Proc; 2007 Oct; 39(8):2563-4. PubMed ID: 17954174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.